Home > Insider Trading > Filing (0001649094-25-000039)

Filing Details

Accession Number:: 0001649094-25-000039
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-03 21:14:29
Reporting Period:: 2025-02-27

Filing Date:: 2025-03-03
Accepted Time:: 2025-03-03 21:14:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649094	Vaxcyte Inc.	PCVX	Biological Products, (No Disgnostic Substances) (2836)	464233385

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1813798	Jim Wassil	C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-02-27	21,726	$0.00	153,421	No	4	A	Direct
Common Stock	Acquisiton	2025-02-28	5,649	$73.02	159,070	No	4	A	Direct
Common Stock	Disposition	2025-02-28	2,869	$73.02	156,201	No	4	F	Direct
Common Stock	Disposition	2025-02-28	1,270	$73.02	154,931	No	4	F	Direct
Common Stock	Acquisiton	2025-03-03	2,638	$2.42	157,569	No	4	M	Direct
Common Stock	Acquisiton	2025-03-03	5,362	$5.35	162,931	No	4	M	Direct
Common Stock	Disposition	2025-03-03	5,915	$73.07	157,016	No	4	S	Direct
Common Stock	Disposition	2025-03-03	2,085	$73.84	154,931	No	4	S	Direct
Common Stock	Disposition	2025-03-03	3,015	$72.10	151,916	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2025-02-27	72,536	$0.00	72,536	$74.22
Common Stock	Stock Option (right to buy)	Disposition	2025-03-03	2,638	$0.00	2,638	$2.42
Common Stock	Stock Option (right to buy)	Disposition	2025-03-03	5,362	$0.00	5,362	$5.35

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
72,536	2035-02-26	No	4	A	Direct
0	2029-12-16	No	4	M	Direct
71,664	2030-04-17	No	4	M	Direct

Footnotes

Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
Represents RSUs issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. The RSUs are fully vested upon the date of grant.
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024.
The price reported is a weighted-average price. The shares were sold at prices ranging from $72.50 to $73.47. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $73.51 to $74.41. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
Option is fully vested and exercisable.